Journal of the Bahrain Medical Society
Year 2021, Volume 33, Issue 1, Pages 42-46
https://doi.org/10.26715/jbms.33_2020_1_9Fathelrhman Ali Eltayeb*, Jalal Abdulla Alkhan
1Department of Anaesthesia & ICU, Field Intensive Care Unit (FICU), Bahrain Defense Force Royal Medical Services.
*Corresponding author: Fathelrhman Ali Eltayeb Idriss, Department of Anaesthesia & ICU, Field Intensive Care Unit (FICU), Bahrain Defense Force Royal Medical Services; Tel. No.: 0097336593169; Email: fathi19737@yahoo.com
Received date: November 23, 2020; Accepted date: December 28, 2020; Published date: March 31, 2021
Abstract
Coronavirus disease 2019 (COVID-19) is a contagious infection caused by the newly discovered severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel virus causing from very mild symptoms to severe symptoms associated with high morbidity and mortality. The most common symptoms of COVID-19 are fever, dry mouth and tiredness, sore throat, headache, loss of taste or smell, diarrhea, conjunctivitis, and sometimes a skin rash. In severe cases, some patients require mechanical ventilator support in a prone position to improve their oxygenation. In extreme cases, despite all the above measures, patients are required to have extracorporeal membrane oxygenation (ECMO) support to improve oxygenation. The two most common types of ECMO are veno-arterial (VA) and venovenous (VV). This case report presents a positive outcome when VV-ECMO was used in COVID-19 patients with acute respiratory distress syndrome at the hospital’s field intensive care unit.
Keywords: COVID-19; Dyspnea; Extracorporeal Membrane Oxygenation; Hypoxia, Respiratory Distress Syndrome.